Merck to gobble up Schering for $41b
China Daily | Updated: 2009-03-10 08:17
|
A Schering-Plough Corp technician attaches a hose to the manifold of a chemical reactor at a plant in Singapore. Bloomberg News |
Merck & Co agreed to buy rival US drugmaker Schering-Plough Corp for $41.1 billion in cash and stock to get a larger experimental pipeline and products unhindered by imminent patent losses.
Photo
